TY  - JOUR
AU  - Lopez-Rodriguez, Rosario
AU  - Perez-Pampin, Eva
AU  - Marquez, Ana
AU  - Blanco, Francisco J
AU  - Joven, Beatriz
AU  - Carreira, Patricia
AU  - Ferrer, Miguel Angel
AU  - Caliz, Rafael
AU  - Valor, Lara
AU  - Narvaez, Javier
AU  - Cañete, Juan D
AU  - Ordoñez, Maria Del Carmen
AU  - Manrique-Arija, Sara
AU  - Vasilopoulos, Yiannis
AU  - Balsa, Alejandro
AU  - Pascual-Salcedo, Dora
AU  - Moreno-Ramos, Manuel J
AU  - Alegre-Sancho, Juan Jose
AU  - Navarro-Sarabia, Federico
AU  - Moreira, Virginia
AU  - Garcia-Portales, Rosa
AU  - Raya, Enrique
AU  - Magro-Checa, Cesar
AU  - Martin, Javier
AU  - Gomez-Reino, Juan J
AU  - Gonzalez, Antonio
PY  - 2018
DO  - 10.1371/journal.pone.0196793
UR  - http://hdl.handle.net/10668/12431
T2  - PloS one
AB  - Genetic biomarkers are sought to personalize treatment of patients with rheumatoid arthritis (RA), given their variable response to TNF inhibitors (TNFi). However, no genetic biomaker is yet sufficiently validated. Here, we report a validation study...
LA  - en
PB  - Public Library of Science
KW  - Antirheumatic agents
KW  - Genetic markers
KW  - Tumor necrosis factor-alpha
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - Female
KW  - Genetic Markers
KW  - Genotype
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Reproducibility of Results
KW  - Tumor Necrosis Factor-alpha
TI  - Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.
TY  - research article
VL  - 13
ER  -